The Calm Between Storms
Serum Biomarkers in Assessing Interattack Astrocytopathy in Neuromyelitis Optica Spectrum Disorder
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 1, 2021
- Accepted in final form February 24, 2021
- First Published April 9, 2021.
Author Disclosures
- Carolyn Goldschmidt, DO (carolyngoldschmidt@gmail.com) and
- Robert A. Bermel, MD
- Carolyn Goldschmidt, DO (carolyngoldschmidt@gmail.com) and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Robert A. Bermel, MD
Biogen, EMD Serono, Genentech, Genzyme, Novartis, VielaBio
NONE
NONE
NONE
NONE
NONE
NONE
Biogen, Genzyme, Genentech, Novartis, Roche
NONE
NONE
Cleveland Clinic shares rights to intellectual property underlying the MSPT, currently licensed to Qr8 Health and Biogen.
Novartis, Genentech, Biogen
NONE
NONE
NONE
NONE
NONE
Robert Bermel shares rights to intellectual property underlying the MSPT, currently licensed to Qr8 Health and Biogen
NONE
NONE
NONE
- From the Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio.
- Correspondence
Dr. Bermel bermelr{at}ccf.org
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSDMitsuru Watanabe, Yuri Nakamura, Zuzanna Michalak et al.Neurology, August 30, 2019 -
Article
Investigating the Presence of Interattack Astrocyte Damage in Neuromyelitis Optica Spectrum DisorderLongitudinal Analysis of Serum Glial Fibrillary Acidic ProteinJae-Won Hyun, Yeseul Kim, So Yeon Kim et al.Neurology: Neuroimmunology & Neuroinflammation, April 09, 2021 -
Article
Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated diseaseHyunjin Kim, Eun-Jae Lee, Seungmi Kim et al.Neurology: Neuroimmunology & Neuroinflammation, March 17, 2020 -
Article
Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica DisorderNicolas Collongues, Cecilia Alves Do Rego, Bertrand Bourre et al.Neurology, February 24, 2021